You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moderna mRNA vaccine

Showing 1 - 25 of 8,832
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19
  • mRNA-1273
  • Pasadena, California
    Kaiser Permanente Southern California
Jul 5, 2023

Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)

Completed
  • Healthy
  • Chronic Stable Illness
  • Little Rock, Arkansas
  • +5 more
Jan 9, 2023

COVID-19 Vaccines Trial in Paris (2nd booster with Comirnaty® (Pfizer-BioNTech), CoV2 preS dTM adjuvanted vaccine (B.1.351),

Active, not recruiting
  • COVID-19 Vaccines
  • 2nd booster with Comirnaty® (Pfizer-BioNTech)
  • CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022

COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)

Not yet recruiting
  • COVID-19
  • Bivalent Moderna
  • Novavax
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023

Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))

Active, not recruiting
  • Lung Transplant Recipient
  • +2 more
  • mRNA-1273 (Moderna COVID-19 vaccine)
  • Los Angeles, California
    UCLA Clinical Translational Research Center
Dec 13, 2022

HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

Recruiting
  • HIV
  • +5 more
  • Pfizer Bivalent COVID-19 Vaccine
  • Moderna Bivalent mRNA vaccine
  • Melbourne, Victoria, Australia
    Alfred Health
Jan 31, 2023

Vaccine Response Impaired, Immune Suppression, Covid19 Trial in Toronto (mRNA-1273 vaccine, Normal Saline Placebo)

Completed
  • Vaccine Response Impaired
  • +2 more
  • mRNA-1273 vaccine
  • Normal Saline Placebo
  • Toronto, Ontario, Canada
  • +1 more
Jul 29, 2022

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

HIV-1-infection Trial in Kigali, Johannesburg (eOD-GT8 60mer mRNA Vaccine (100µg))

Active, not recruiting
  • HIV-1-infection
  • eOD-GT8 60mer mRNA Vaccine (100µg)
  • Kigali, Rwanda
  • +1 more
Sep 9, 2022

COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among

Active, not recruiting
  • Covid19
  • SARS-CoV2 Infection
  • mRNA-1273
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2022

COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)

Recruiting
  • COVID-19
  • Corona Virus Infection
  • Pfizer-BioNTech mRNA COVID-19 vaccine
  • Moderna mRNA COVID-19 vaccine
  • Ann Arbor, Michigan
    University of Michigan
Apr 23, 2022

Risk Factors of Myocarditis and Pericarditis After Moderna

Active, not recruiting
  • Myocarditis, Pericarditis
  • mRNA-1273
  • Aarhus, Denmark
  • +4 more
Oct 31, 2023

Nipah Virus Infection Trial run by the NIAID (mRNA -1215)

Recruiting
  • Nipah Virus Infection
  • mRNA -1215
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 30, 2022

COVID-19 Breakthrough Infection in Fully Vaccinated People and

Enrolling by invitation
  • COVID-19 Pneumonia
  • COVID-19
  • Pfizer COVID-19 mRNA vaccine
  • Moderna COVID-19 mRNA vaccine
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, mRNA vaccine manufactured by Pfizer or Moderna)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01C
  • +3 more
  • (no location specified)
Apr 1, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,

Recruiting
  • Kidney Transplant Recipients
  • Liver Transplant Recipients
  • Pfizer-BioNTech Bivalent COVID-19 Vaccine
  • +3 more
  • San Diego, California
  • +14 more
Oct 31, 2022

COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Recombinant COVID-19 variant Vaccine (Sf9 Cell)
  • +3 more
  • Morelia, Michoacán De Ocampo, Mexico
    Clínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022

Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)

Active, not recruiting
  • Chronic Kidney Diseases
  • COVID-19
  • Pfizer-BioNTech COVID-19 Vaccine
  • MODERNA SARS-CoV-2 Vaccine
  • Scarborough, Ontario, Canada
  • +2 more
Aug 5, 2022

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine

Active, not recruiting
  • Immunocompromised Patients
  • Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
  • Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
  • Basel, Switzerland
  • +3 more
Oct 18, 2022

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose Trial in Paris

Active, not recruiting
  • Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
  • Pfizer
  • Moderna
  • Paris, France
    CIC 1417 Cochin-Pasteur
Jul 31, 2021

The Impact of COVID-19 on Maternal and Neonatal Outcomes

Recruiting
  • COVID-19
  • Pregnancy; Infection
  • mRNA COVID-19 vaccine (Pfizer or Moderna)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jan 14, 2022

Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))

Active, not recruiting
  • Kidney Transplant Recipients
  • mRNA-1273 vaccine (Pfizer/BioNTech)
  • mRNA-1273 vaccine (Moderna)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Oct 4, 2021